|
Name |
Azulene, 1,2,3,4,5,6,7,8-octahydro-1,4-dimethyl-7-(1-methylethenyl)-, (1S,4S,7R)-
|
| Molecular Formula | C15H24 | |
| IUPAC Name* |
1,4-dimethyl-7-prop-1-en-2-yl-1,2,3,4,5,6,7,8-octahydroazulene
|
|
| SMILES |
CC1CCC(CC2=C1CCC2C)C(=C)C
|
|
| InChI |
InChI=1S/C15H24/c1-10(2)13-7-5-11(3)14-8-6-12(4)15(14)9-13/h11-13H,1,5-9H2,2-4H3
|
|
| InChIKey |
ADIDQIZBYUABQK-UHFFFAOYSA-N
|
|
| Synonyms |
alpha-Guajene; Azulene, 1,2,3,4,5,6,7,8-octahydro-1,4-dimethyl-7-(1-methylethenyl)-, (1S,4S,7R)-; 7-Isopropenyl-1,4-dimethyl-1,2,3,4,5,6,7,8-octahydroazulene; ABQ2CB7VAC; a-Guaiene; UNII-ABQ2CB7VAC; 1(5),11-Guaiadiene; 7-Isopropenyl-1,4-dimethyl-1,2,3,4,5,6,7,8-octahydroazulene-, [1S-(1.alpha.,4.alpha.,7.alpha.)]-; FT-0699683; Q67879675
|
|
| CAS | 3691-12-1 | |
| PubChem CID | 107152 | |
| ChEMBL ID | NA |
Chemical Classification: |
|
|
|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
|---|---|---|---|---|---|---|---|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
| Molecular Weight: | 204.35 | ALogp: | 4.6 |
| HBD: | 0 | HBA: | 0 |
| Rotatable Bonds: | 1 | Lipinski's rule of five: | Accepted |
| Polar Surface Area: | 0.0 | Aromatic Rings: | 2 |
| Heavy Atoms: | 15 | QED Weighted: | 0.518 |
| Caco-2 Permeability: | -4.536 | MDCK Permeability: | 0.00001750 |
| Pgp-inhibitor: | 0.826 | Pgp-substrate: | 0 |
| Human Intestinal Absorption (HIA): | 0.003 | 20% Bioavailability (F20%): | 0.178 |
| 30% Bioavailability (F30%): | 0.012 |
| Blood-Brain-Barrier Penetration (BBB): | 0.827 | Plasma Protein Binding (PPB): | 95.72% |
| Volume Distribution (VD): | 3.563 | Fu: | 2.09% |
| CYP1A2-inhibitor: | 0.38 | CYP1A2-substrate: | 0.747 |
| CYP2C19-inhibitor: | 0.136 | CYP2C19-substrate: | 0.86 |
| CYP2C9-inhibitor: | 0.213 | CYP2C9-substrate: | 0.608 |
| CYP2D6-inhibitor: | 0.058 | CYP2D6-substrate: | 0.918 |
| CYP3A4-inhibitor: | 0.454 | CYP3A4-substrate: | 0.569 |
| Clearance (CL): | 9.952 | Half-life (T1/2): | 0.061 |
| hERG Blockers: | 0.017 | Human Hepatotoxicity (H-HT): | 0.114 |
| Drug-inuced Liver Injury (DILI): | 0.422 | AMES Toxicity: | 0.015 |
| Rat Oral Acute Toxicity: | 0.03 | Maximum Recommended Daily Dose: | 0.55 |
| Skin Sensitization: | 0.032 | Carcinogencity: | 0.861 |
| Eye Corrosion: | 0.004 | Eye Irritation: | 0.222 |
| Respiratory Toxicity: | 0.614 |
| Similar NPs | Similar Drugs | ||||||
|---|---|---|---|---|---|---|---|
| NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
| ENC001619 | ![]() |
1.000 | D0I2SD | ![]() |
0.225 | ||
| ENC001013 | ![]() |
0.585 | D04SFH | ![]() |
0.225 | ||
| ENC000567 | ![]() |
0.489 | D0F1UL | ![]() |
0.221 | ||
| ENC000808 | ![]() |
0.464 | D07BSQ | ![]() |
0.221 | ||
| ENC001295 | ![]() |
0.390 | D0G8OC | ![]() |
0.210 | ||
| ENC000787 | ![]() |
0.390 | D04CSZ | ![]() |
0.207 | ||
| ENC000411 | ![]() |
0.373 | D0W3OS | ![]() |
0.207 | ||
| ENC001832 | ![]() |
0.367 | D0B4RU | ![]() |
0.207 | ||
| ENC001924 | ![]() |
0.367 | D0K0EK | ![]() |
0.205 | ||
| ENC001437 | ![]() |
0.344 | D0T7ZQ | ![]() |
0.205 | ||